Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines for patients with significant unmet medical needs. A number of the currently approved biotechnology products originated from or are based on Genentech science. We commercialize multiple biotechnology products and also receive royalties from companies that are licensed to market products based on our technology. See “Marketed Products” and “Licensed Products” below. Genentech was organized in 1976 as a California corporation and was reincorporated in Delaware in 1987.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
942347624
Latest filings (excl ownership)
UPLOAD
Letter from SEC
14 Apr 09
UPLOAD
Letter from SEC
14 Apr 09
UPLOAD
Letter from SEC
14 Apr 09
UPLOAD
Letter from SEC
14 Apr 09
25-NSE
Exchange delisting
27 Mar 09
EFFECT
Notice of effectiveness
27 Mar 09
15-12B
Securities registration termination
26 Mar 09
8-K
Departure of Directors or Certain Officers
26 Mar 09
POS AM
Prospectus update (post-effective amendment)
26 Mar 09
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Mar 09
Latest ownership filings
11-K
Annual report of employee stock purchases
24 Jun 08
11-K
Annual report of employee stock purchases
20 Jun 07
11-K
Annual report of employee stock purchases
14 Jun 06
11-K
Annual report of employee stock purchases
13 Jun 05
11-K
Annual report of employee stock purchases
10 Jun 04
11-K
Annual report of employee stock purchases
30 Jun 03
11-K
Annual report of employee stock purchases
12 Jun 02
11-K
Annual report of employee stock purchases
18 Jun 01
11-K
Annual report of employee stock purchases
13 Jun 00
11-K
Annual report of employee stock purchases
25 Jun 99